Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.73% |
| 2 | Technology | 14.98% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZOES
2026
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $3.39M | ﹤0.01% |
266,600
-111,800
| -30% | -$1.27M |
|
2027
Invesco Mortgage Capital
IVR
$802M
| $3.38M | ﹤0.01% |
21,350
-8,503
| -28% | -$1.37M |
|
|
NTUS
2028
DELISTED
Natus Medical Inc
NTUS
| $3.35M | ﹤0.01% |
94,089
+26,744
| +40% | +$944K |
|
|
SDRL
2029
DELISTED
Seadrill Limited Common Stock
SDRL
| $3.35M | ﹤0.01% |
+134,889
| New | +$2.74M |
|
|
EIGR
2030
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.35M | ﹤0.01% |
9,294
+1,620
| +21% | +$554K |
|
2031
Travel + Leisure Co
TNL
$4.58B
| $3.33M | ﹤0.01% |
76,900
+16,123
| +27% | +$715K |
|
|
FLY
2032
DELISTED
Fly Leasing Limited
FLY
| $3.33M | ﹤0.01% |
236,400
-37,880
| -14% | -$535K |
|
2033
Alico
ALCO
$308M
| $3.32M | ﹤0.01% |
98,291
+31,000
| +46% | +$1M |
|
2034
Westlake Chemical Partners
WLKP
$778M
| $3.32M | ﹤0.01% |
133,378
-7,639
| -5% | -$194K |
|
|
JAX
2035
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $3.31M | ﹤0.01% |
278,200
+28,000
| +11% | +$326K |
|
2036
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $3.31M | ﹤0.01% |
122,700
-69,600
| -36% | -$1.88M |
|
2037
Knowles
KN
$3.23B
| $3.31M | ﹤0.01% |
198,978
+187,804
| +1,681% | +$3.16M |
|
2038
Cameco
CCJ
$43.1B
| $3.3M | ﹤0.01% |
289,500
-134,700
| -32% | -$1.42M |
|
2039
AmeriServ Financial
ASRV
$84.3M
| $3.29M | ﹤0.01% |
764,614
+78,715
| +11% | +$344K |
|
2040
Silvercrest Asset Management
SAMG
$78.6M
| $3.26M | ﹤0.01% |
235,300
+30,000
| +15% | +$483K |
|
2041
RCM Technologies
RCMT
$202M
| $3.25M | ﹤0.01% |
760,243
-23,027
| -3% | -$110K |
|
2042
Varonis Systems
VRNS
$4.82B
| $3.24M | ﹤0.01% |
132,600
-1,149,300
| -90% | -$27.9M |
|
|
SPRT
2043
DELISTED
support.com, Inc.
SPRT
| $3.23M | ﹤0.01% |
1,112,163
-19,800
| -2% | -$55.1K |
|
|
ORBC
2044
DELISTED
ORBCOMM, Inc.
ORBC
| $3.23M | ﹤0.01% |
297,000
-401,618
| -57% | -$4.25M |
|
2045
National Bankshares
NKSH
$271M
| $3.22M | ﹤0.01% |
70,935
-1,265
| -2% | -$58.8K |
|
|
DCP
2046
DELISTED
DCP Midstream, LP
DCP
| $3.22M | ﹤0.01% |
81,433
+65,877
| +423% | +$2.77M |
|
2047
Wipro
WIT
$19.3B
| $3.19M | ﹤0.01% |
1,635,467
-37,333
| -2% | -$72K |
|
|
LUMO
2048
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.19M | ﹤0.01% |
148,442
+103,431
| +230% | +$3.15M |
|
|
VSI
2049
DELISTED
Vitamin Shoppe Inc.
VSI
| $3.19M | ﹤0.01% |
+318,608
| New | +$3.29M |
|
2050
Flexsteel Industries
FLXS
$301M
| $3.18M | ﹤0.01% |
106,800
+15,400
| +17% | +$549K |
|
Similar funds
Jim Simons's Q3 2018 Portfolio in Review
As of Q3 2018, Jim Simons held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Jim Simons's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Jim Simons added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Jim Simons's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Jim Simons fully exited Apple in Q3 2018, selling an estimated $707M.
- Jim Simons's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Jim Simons opened 508 new positions and closed 410 in Q3 2018.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.